No­vo Nordisk forms car­diometa­bol­ic drug dis­cov­ery ac­cel­er­a­tor to get to re­search faster

No­vo Nordisk is now tap­ping in­to ear­li­er stages of car­diometa­bol­ic re­search by bring­ing to­geth­er aca­d­e­m­ic in­sti­tu­tions and Ger­man drug dis­cov­ery shop Evotec af­ter it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.